-
1
-
-
0242319672
-
Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis
-
Afuwape, A.O., M. Feldmann and E.M. Paleolog, 2003a. Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis. Gene Ther. 10: 1950-1960.
-
(2003)
Gene Ther
, vol.10
, pp. 1950-1960
-
-
Afuwape, A.O.1
Feldmann, M.2
Paleolog, E.M.3
-
2
-
-
0036068479
-
The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis
-
Afuwape, A.O., S. Kiriakidis and E.M. Paleolog, 2003b. The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histol. Histopathol., 17: 961-972.
-
(2003)
Histol. Histopathol
, vol.17
, pp. 961-972
-
-
Afuwape, A.O.1
Kiriakidis, S.2
Paleolog, E.M.3
-
3
-
-
0038575364
-
Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: Implications for therapy
-
Andreakos, E., C. Smith, S. Kiriakidis, C. Monaco, R. de Martin, F.M. Brennan, E. Paleolog, M. Feldmann and B.M. Foxwell, 2003. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: Implications for therapy. Arthritis. Rheum., 48: 1901-1912.
-
(2003)
Arthritis. Rheum
, vol.48
, pp. 1901-1912
-
-
Andreakos, E.1
Smith, C.2
Kiriakidis, S.3
Monaco, C.4
de Martin, R.5
Brennan, F.M.6
Paleolog, E.7
Feldmann, M.8
Foxwell, B.M.9
-
4
-
-
0023945481
-
The American Rheumatism Association 1987 revised criteria for the classification of Rheumatoid Arthritis
-
Arnett, F.C., S.M. Edworthy, D.A. Bloch et al., 1988. The American Rheumatism Association 1987 revised criteria for the classification of Rheumatoid Arthritis. Arthritis. Rheum., 31: 315-324.
-
(1988)
Arthritis. Rheum
, vol.31
, pp. 315-324
-
-
Arnett, F.C.1
Edworthy, S.M.2
Bloch, D.A.3
-
5
-
-
0035460227
-
Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis
-
Ballara, S., P.C. Taylor, P. Reusch, D. Marme, M. Feldmann, R.N. Maini and E.M. Paleolog, 2001. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum., 44: 2055-64.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 2055-2064
-
-
Ballara, S.1
Taylor, P.C.2
Reusch, P.3
Marme, D.4
Feldmann, M.5
Maini, R.N.6
Paleolog, E.M.7
-
6
-
-
0008362637
-
Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts
-
Berse, B., J.A. Hunt, R.J. Diegel, P. Morganelli, K. Yeo, F. Brown and R.A. Fava, 1999. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin. Exp. Immunol., 115: 176-182.
-
(1999)
Clin. Exp. Immunol
, vol.115
, pp. 176-182
-
-
Berse, B.1
Hunt, J.A.2
Diegel, R.J.3
Morganelli, P.4
Yeo, K.5
Brown, F.6
Fava, R.A.7
-
7
-
-
0033956368
-
Placenta Growth Factor (PIGF) induces Vascular Endothelial Growth Factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid
-
Bottomley, M.J., N.J. Webb, C.J. Watson, L. Holt, M. Bukhari, J. Denton, A.J. Freemont and P.E. Brenchley, 2000. Placenta Growth Factor (PIGF) induces Vascular Endothelial Growth Factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin. Exp. Immunol., 119: 182-188.
-
(2000)
Clin. Exp. Immunol
, vol.119
, pp. 182-188
-
-
Bottomley, M.J.1
Webb, N.J.2
Watson, C.J.3
Holt, L.4
Bukhari, M.5
Denton, J.6
Freemont, A.J.7
Brenchley, P.E.8
-
8
-
-
0347928884
-
High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies
-
Drouart, M., P. Saas, M. Billot, J.P. Cedoz, P. Tiberghien, D. Wendling and E. Toussirot, 2003. High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin. Exp. Immunol., 132: 158-162.
-
(2003)
Clin. Exp. Immunol
, vol.132
, pp. 158-162
-
-
Drouart, M.1
Saas, P.2
Billot, M.3
Cedoz, J.P.4
Tiberghien, P.5
Wendling, D.6
Toussirot, E.7
-
9
-
-
0037222724
-
Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage
-
Enomoto, H., I. Inoki, K. Komiya, T. Shiomi, E. Ikeda, K. Obata, H. Matsumoto, Y. Toyama and Y. Okada, 2003. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am. J. Pathol., 162: 171-181.
-
(2003)
Am. J. Pathol
, vol.162
, pp. 171-181
-
-
Enomoto, H.1
Inoki, I.2
Komiya, K.3
Shiomi, T.4
Ikeda, E.5
Obata, K.6
Matsumoto, H.7
Toyama, Y.8
Okada, Y.9
-
10
-
-
0028216495
-
Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
-
Fava, R.A., N.J. Olsen, G. Spencer-Green, K.T. Yeo, T.K. Yeo, B. Berse, R.W. Jackman, D.R. Senger, H.F. Dvorak and L.F. Brown, 1994. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med., 180: 341-346.
-
(1994)
J. Exp. Med
, vol.180
, pp. 341-346
-
-
Fava, R.A.1
Olsen, N.J.2
Spencer-Green, G.3
Yeo, K.T.4
Yeo, T.K.5
Berse, B.6
Jackman, R.W.7
Senger, D.R.8
Dvorak, H.F.9
Brown, L.F.10
-
11
-
-
0242335590
-
Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis
-
Giatromanolaki, A., E. Sivridis, E. Maltezos, N. Athanassou, D. Papazoglou, K.C. Gatter, A.L. Harris and M.I. Koukourakis, 2003. Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res. Ther., 5: R193-201.
-
(2003)
Arthritis Res. Ther
, vol.5
-
-
Giatromanolaki, A.1
Sivridis, E.2
Maltezos, E.3
Athanassou, N.4
Papazoglou, D.5
Gatter, K.C.6
Harris, A.L.7
Koukourakis, M.I.8
-
12
-
-
10744222202
-
Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis
-
Gudbjörnsson, B., R. Christofferson and A. Larsson, 2004. Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis. Scand. J. Clin. Lab. Invest., 64: 9-16.
-
(2004)
Scand. J. Clin. Lab. Invest
, vol.64
, pp. 9-16
-
-
Gudbjörnsson, B.1
Christofferson, R.2
Larsson, A.3
-
13
-
-
15144340197
-
Vascular endothelial growth factor in patients with rheumatoid arthritis
-
Harada, M., K. Mitsuyama, H. Yoshida, S. Sakisaka, E. Taniguchi, T. Kawaguchi, M. Ariyoshi, T. Saiki, M. Sakamoto, K. Nagata, M. Sata, K. Matsuo and K. Tanikawa, 1998. Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand. J. Rheumatol., 27: 377-380.
-
(1998)
Scand. J. Rheumatol
, vol.27
, pp. 377-380
-
-
Harada, M.1
Mitsuyama, K.2
Yoshida, H.3
Sakisaka, S.4
Taniguchi, E.5
Kawaguchi, T.6
Ariyoshi, M.7
Saiki, T.8
Sakamoto, M.9
Nagata, K.10
Sata, M.11
Matsuo, K.12
Tanikawa, K.13
-
14
-
-
0036822541
-
Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts
-
Hitchon, C., K. Wong, G. Ma, J. Reed, D. Lyttle and H. El-Gabalawy, 2002. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis. Rheum., 46: 2587-2597.
-
(2002)
Arthritis. Rheum
, vol.46
, pp. 2587-2597
-
-
Hitchon, C.1
Wong, K.2
Ma, G.3
Reed, J.4
Lyttle, D.5
El-Gabalawy, H.6
-
15
-
-
0033850719
-
Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA)
-
Kasama, T., K. Kobayashi, N. Yajima, F. Shiozawa, Y. Yoda, H.T. Takeuchi, Y. Mori, M. Negishi, H. Ide and M. Adachi, 2000. Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA). Clin. Exp. Immunol., 121: 533-538.
-
(2000)
Clin. Exp. Immunol
, vol.121
, pp. 533-538
-
-
Kasama, T.1
Kobayashi, K.2
Yajima, N.3
Shiozawa, F.4
Yoda, Y.5
Takeuchi, H.T.6
Mori, Y.7
Negishi, M.8
Ide, H.9
Adachi, M.10
-
16
-
-
0035152825
-
Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: Critical involvement of the interaction with synovial fibroblasts
-
Kasama, T., F. Shiozawa, K. Kobayashi, N. Yajima, M. Hanyuda, H.T. Takeuchi, Y. Mori, M. Negishi, H. Ide and M. Adachi, 2001. Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: Critical involvement of the interaction with synovial fibroblasts. Arthritis Rheum., 44: 2512-2524.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 2512-2524
-
-
Kasama, T.1
Shiozawa, F.2
Kobayashi, K.3
Yajima, N.4
Hanyuda, M.5
Takeuchi, H.T.6
Mori, Y.7
Negishi, M.8
Ide, H.9
Adachi, M.10
-
17
-
-
0032435446
-
Serum concentrations of vascular endothelial growth factor in collagen diseases
-
Kikuchi, K., M. Kubo, T. Kadono, N. Yazawa, H. Ihn and K. Tamaki, 1998. Serum concentrations of vascular endothelial growth factor in collagen diseases. Br. J. Dermatol., 139: 1049-1051.
-
(1998)
Br. J. Dermatol
, vol.139
, pp. 1049-1051
-
-
Kikuchi, K.1
Kubo, M.2
Kadono, T.3
Yazawa, N.4
Ihn, H.5
Tamaki, K.6
-
18
-
-
0028199835
-
Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis
-
Koch, A.E., L.A. Harlow, G.K. Haines, E.P. Amento, E.N. Unemori, W.L. Wong and R.M. Pope, N. Ferrara, 1994. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol., 152: 4149-4156.
-
(1994)
J. Immunol
, vol.152
, pp. 4149-4156
-
-
Koch, A.E.1
Harlow, L.A.2
Haines, G.K.3
Amento, E.P.4
Unemori, E.N.5
Wong, W.L.6
Pope, R.M.7
Ferrara, N.8
-
19
-
-
0035034353
-
Longitudinal study of rheumatoid arthritis patients discloses sustained elevated serum levels of soluble CD106 (V-CAM)
-
Kolopp-Sarda, M.N., F. Guillemin, I. Chary-Valckenaere, M.C. Bene, J. Pourel and G.C. Faure, 2001. Longitudinal study of rheumatoid arthritis patients discloses sustained elevated serum levels of soluble CD106 (V-CAM). Clin. Exp. Rheumatol., 19: 165-170.
-
(2001)
Clin. Exp. Rheumatol
, vol.19
, pp. 165-170
-
-
Kolopp-Sarda, M.N.1
Guillemin, F.2
Chary-Valckenaere, I.3
Bene, M.C.4
Pourel, J.5
Faure, G.C.6
-
20
-
-
0035678531
-
Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? A clinical, radiological and pathological study in 12 patients monitored for 10 years
-
Latour, F., L. Zabraniecki, C. Dromer, A. Brouchet, R. Durroux and B. Fournie, 2001. Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? A clinical, radiological and pathological study in 12 patients monitored for 10 years. Joint Bone Spine, 68: 493-498.
-
(2001)
Joint Bone Spine
, vol.68
, pp. 493-498
-
-
Latour, F.1
Zabraniecki, L.2
Dromer, C.3
Brouchet, A.4
Durroux, R.5
Fournie, B.6
-
21
-
-
0034988575
-
Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis
-
Lee, S.S., Y.S. Joo, W.U. Kim, D.J. Min J.K. Min, S.H. Park, C.S. Cho and H.Y. Kim, 2001. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Rheumatol., 19: 321-324.
-
(2001)
Clin. Exp. Rheumatol
, vol.19
, pp. 321-324
-
-
Lee, S.S.1
Joo, Y.S.2
Kim, W.U.3
Min, D.J.4
Min, J.K.5
Park, S.H.6
Cho, C.S.7
Kim, H.Y.8
-
22
-
-
0034114929
-
Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis
-
Lu, J., T. Kasama, K. Kobayashi, Y. Yoda, F. Shiozawa, M. Hanyuda, M. Negishi, H. Ide and M. Adachi, 2000. Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J. Immunol., 164: 5922-5927.
-
(2000)
J. Immunol
, vol.164
, pp. 5922-5927
-
-
Lu, J.1
Kasama, T.2
Kobayashi, K.3
Yoda, Y.4
Shiozawa, F.5
Hanyuda, M.6
Negishi, M.7
Ide, H.8
Adachi, M.9
-
23
-
-
0019379478
-
The assessment of disease activity in rheumatoid arthritis using multivariant analysis
-
Mallaya, R.K. and B.E.W. Mace, 1981. The assessment of disease activity in rheumatoid arthritis using multivariant analysis. Rheumatology and Rehabilitation, 20: 14-17.
-
(1981)
Rheumatology and Rehabilitation
, vol.20
, pp. 14-17
-
-
Mallaya, R.K.1
Mace, B.E.W.2
-
24
-
-
0033888921
-
Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis
-
Miotla, J., R. Maciewicz, J. Kendrew, M. Feldmann and E. Paleolog, 2000. Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest., 80: 1195-205.
-
(2000)
Lab Invest
, vol.80
, pp. 1195-1205
-
-
Miotla, J.1
Maciewicz, R.2
Kendrew, J.3
Feldmann, M.4
Paleolog, E.5
-
25
-
-
0033786484
-
Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis
-
Nagashima, M., G. Asano and S. Yoshino, 2000a. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis. J. Rheumatol., 27: 2339-2342.
-
(2000)
J. Rheumatol
, vol.27
, pp. 2339-2342
-
-
Nagashima, M.1
Asano, G.2
Yoshino, S.3
-
26
-
-
0038798085
-
Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis
-
Nakahara, H., J. Song, M. Sugimoto, K. Hagihara, T. Kishimoto, K. Yoshizaki and N. Nishimoto, 2003. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum., 48: 1521-1529.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 1521-1529
-
-
Nakahara, H.1
Song, J.2
Sugimoto, M.3
Hagihara, K.4
Kishimoto, T.5
Yoshizaki, K.6
Nishimoto, N.7
-
27
-
-
0036137724
-
Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium
-
Paavonen, K., J. Mandelin, T. Partanen, L. Jussila, T.F. Li, A. Ristimaki, K. Alitalo and Y.T. Konttinen, 2002. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. J. Rheumatol., 29: 39-45.
-
(2002)
J. Rheumatol
, vol.29
, pp. 39-45
-
-
Paavonen, K.1
Mandelin, J.2
Partanen, T.3
Jussila, L.4
Li, T.F.5
Ristimaki, A.6
Alitalo, K.7
Konttinen, Y.T.8
-
28
-
-
0030266845
-
Angiogenesis: A Critical Process in the Pathogenesis of RA-A Role For VEGF?
-
Paleolog, E.M., 1996. Angiogenesis: A Critical Process in the Pathogenesis of RA-A Role For VEGF?. Br. J. Rheumatol., 35: 917-920.
-
(1996)
Br. J. Rheumatol
, vol.35
, pp. 917-920
-
-
Paleolog, E.M.1
-
29
-
-
0031725440
-
Angiogenesis in rheumatoid arthritis: Implications for future therapeutic strategies
-
Paleolog, E.M. and R.A. Fava, 1998. Angiogenesis in rheumatoid arthritis: Implications for future therapeutic strategies. Springer Semin. Immunopathol., 20: 73-94.
-
(1998)
Springer Semin. Immunopathol
, vol.20
, pp. 73-94
-
-
Paleolog, E.M.1
Fava, R.A.2
-
30
-
-
0034781683
-
Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints
-
Pfander, D., D. Kortje, R. Zimmermann, G. Weseloh, T. Kirsch, M. Gesslein, T. Cramer and B. Swoboda, 2001. Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann. Rheum. Dis., 60: 1070-1073.
-
(2001)
Ann. Rheum. Dis
, vol.60
, pp. 1070-1073
-
-
Pfander, D.1
Kortje, D.2
Zimmermann, R.3
Weseloh, G.4
Kirsch, T.5
Gesslein, M.6
Cramer, T.7
Swoboda, B.8
-
31
-
-
0035661541
-
Serum vascular endothelial growth factor in late rheumatoid arthritis
-
Pinheiro, G.R., C.A. Andrade, C.R. Gayer, M.S. Coelho, S.M. Freire and M.A. Scheinberg, 2001. Serum vascular endothelial growth factor in late rheumatoid arthritis. Clin. Exp. Rheumatol., 19: 721-723.
-
(2001)
Clin. Exp. Rheumatol
, vol.19
, pp. 721-723
-
-
Pinheiro, G.R.1
Andrade, C.A.2
Gayer, C.R.3
Coelho, M.S.4
Freire, S.M.5
Scheinberg, M.A.6
-
32
-
-
0036692256
-
Angiogenesis in health and disease: Insights into basic mechanisms and therapeutic opportunities
-
Polverini, P.J., 2002. Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities. J. Dent. Educ., 66: 962-975.
-
(2002)
J. Dent. Educ
, vol.66
, pp. 962-975
-
-
Polverini, P.J.1
-
33
-
-
0034946863
-
Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis
-
Pufe, T., W. Petersen, B. Tillmann and R. Mentlein, 2001. Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis. J. Rheumatol., 28: 1482-1485.
-
(2001)
J. Rheumatol
, vol.28
, pp. 1482-1485
-
-
Pufe, T.1
Petersen, W.2
Tillmann, B.3
Mentlein, R.4
-
34
-
-
0014305869
-
Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis
-
Ritchie, D.M., J.E. Boyle, J.M. Mc Innes, M.K. Jasani, T.G. Dalakos, P. Grieveson and W.W. Buchanan, 1968. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q. J. Med., 147: 393-406.
-
(1968)
Q. J. Med
, vol.147
, pp. 393-406
-
-
Ritchie, D.M.1
Boyle, J.E.2
Mc Innes, J.M.3
Jasani, M.K.4
Dalakos, T.G.5
Grieveson, P.6
Buchanan, W.W.7
-
35
-
-
0032515980
-
An antagonistic Vascular Endothelial Growth Factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells
-
Siemeister, G., M. Schirner, P. Reusch, B. Barleon, D. Marme and G. Martiny-Baron, 1998. An antagonistic Vascular Endothelial Growth Factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc. Natl. Acad. Sci. USA., 95: 4625-4629.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 4625-4629
-
-
Siemeister, G.1
Schirner, M.2
Reusch, P.3
Barleon, B.4
Marme, D.5
Martiny-Baron, G.6
-
36
-
-
17944378767
-
Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity
-
Sone, H., M. Sakauchi, A. Takahashi, H. Suzuki, N. Inoue, K. Iida, H. Shimano, H. Toyoshima, Y. Kawakami, Y. Okuda, K. Matsuo and N. Yamada, 2001. Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity. Life Sci., 69: 1861-1869.
-
(2001)
Life Sci
, vol.69
, pp. 1861-1869
-
-
Sone, H.1
Sakauchi, M.2
Takahashi, A.3
Suzuki, H.4
Inoue, N.5
Iida, K.6
Shimano, H.7
Toyoshima, H.8
Kawakami, Y.9
Okuda, Y.10
Matsuo, K.11
Yamada, N.12
-
37
-
-
34250868143
-
Anti-TNF-α antibody Infliximab and glucocorticoids reduce serum Vascular Endothelial Growth Factor (VEGF) levels in patients with rheumatoid arthritis: A pilot study
-
Strunk, J., E. Heinemann and U. Lange, 2004a. Anti-TNF-α antibody Infliximab and glucocorticoids reduce serum Vascular Endothelial Growth Factor (VEGF) levels in patients with rheumatoid arthritis: A pilot study. Arthritis Res. Ther., 6(Suppl 1): 94.
-
(2004)
Arthritis Res. Ther
, vol.6
, Issue.SUPPL. 1
, pp. 94
-
-
Strunk, J.1
Heinemann, E.2
Lange, U.3
-
38
-
-
34250829422
-
A new approach to study angiogenesis in rheumatoid arthritis by power Doppler sonography and serum vascular endothelial growth factor level measurement
-
Strunk, J., E. Heinemann and U. Lange, 2004b. A new approach to study angiogenesis in rheumatoid arthritis by power Doppler sonography and serum vascular endothelial growth factor level measurement. Arthritis Res. Ther., 6(Suppl 1): 103.
-
(2004)
Arthritis Res. Ther
, vol.6
, Issue.SUPPL. 1
, pp. 103
-
-
Strunk, J.1
Heinemann, E.2
Lange, U.3
-
39
-
-
34247627779
-
VEGF and imaging of vessels in rheumatoid arthritis. Supplement Review
-
Taylor, P.C., 2002. VEGF and imaging of vessels in rheumatoid arthritis. Supplement Review. Arthritis Res., 4 (suppl 3): S99-S107
-
(2002)
Arthritis Res
, vol.4
, Issue.SUPPL. 3
-
-
Taylor, P.C.1
-
40
-
-
0034044350
-
Pharmacoeconomics of drug therapy for rheumatoid arthritis
-
Jun
-
Tugwell, P., 2000. Pharmacoeconomics of drug therapy for rheumatoid arthritis. Rheumatology (Oxford) Jun., 39 Suppl 1: 43-47.
-
(2000)
Rheumatology (Oxford)
, vol.39
, Issue.SUPPL. 1
, pp. 43-47
-
-
Tugwell, P.1
-
41
-
-
0037309232
-
Cytokine production in the infrapatellar fat pad: Another source of cytokines in knee synovial fluids
-
Ushiyama, T., T. Chano, K. Inoue and Y. Matsusue, 2003. Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fluids. Ann. Rheum. Dis., 62: 108-112.
-
(2003)
Ann. Rheum. Dis
, vol.62
, pp. 108-112
-
-
Ushiyama, T.1
Chano, T.2
Inoue, K.3
Matsusue, Y.4
-
42
-
-
0031913045
-
Focally regulated endothelial proliferation and cell death in human synovium
-
Walsh, D.A., M. Wade, P.I. Mapp and D.R. Blake, 1998. Focally regulated endothelial proliferation and cell death in human synovium. Am. J. Pathol., 152: 691-702.
-
(1998)
Am. J. Pathol
, vol.152
, pp. 691-702
-
-
Walsh, D.A.1
Wade, M.2
Mapp, P.I.3
Blake, D.R.4
-
43
-
-
0036139621
-
Expression and localization of vascular endothelial growth factor-C in rheumatoid arthritis synovial tissue
-
Wauke, K., M. Nagashima, T. Ishiwata, G. Asano and S. Yoshino, 2002. Expression and localization of vascular endothelial growth factor-C in rheumatoid arthritis synovial tissue. J. Rheumatol., 29: 34-38.
-
(2002)
J. Rheumatol
, vol.29
, pp. 34-38
-
-
Wauke, K.1
Nagashima, M.2
Ishiwata, T.3
Asano, G.4
Yoshino, S.5
-
44
-
-
0031797701
-
Localization of vascular endothelial growth factor in synovial membrane mast cells: Examination with multi-labelling subtraction immunostaining
-
Yamada, T., M. Sawatsubashi, H. Yakushiji, Y. Itoh, G. Edakuni, M. Mori, L. Robert and K. Miyazaki, 1998. Localization of vascular endothelial growth factor in synovial membrane mast cells: Examination with "multi-labelling subtraction immunostaining. Virchows Arch., 433: 567-570.
-
(1998)
Virchows Arch
, vol.433
, pp. 567-570
-
-
Yamada, T.1
Sawatsubashi, M.2
Yakushiji, H.3
Itoh, Y.4
Edakuni, G.5
Mori, M.6
Robert, L.7
Miyazaki, K.8
-
45
-
-
0036135611
-
Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats
-
Yamashita, A., Y. Yonemitsu, S. Okano, K. Nakagawa, Y. Nakashima, T. Irisa, Y. Iwamoto, Y. Nagai, M. Hasegawa and K. Sueishi, 2002. Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats. J. Immunol., 168: 450-457.
-
(2002)
J. Immunol
, vol.168
, pp. 450-457
-
-
Yamashita, A.1
Yonemitsu, Y.2
Okano, S.3
Nakagawa, K.4
Nakashima, Y.5
Irisa, T.6
Iwamoto, Y.7
Nagai, Y.8
Hasegawa, M.9
Sueishi, K.10
|